This inventor holds 1 USPTO granted patent. Top assignee: Zenyaku Kogyo Kabushiki Kaisha. Active years: 2001.
Company Filing History:
Years Active: 2001
Title: Masahiro Inaba: Innovator in Antitumor Agents
Introduction
Masahiro Inaba is a prominent inventor based in Tokyo, Japan. He is known for his significant contributions to the field of pharmaceuticals, particularly in the development of antitumor agents. His innovative work has led to the creation of compounds that hold promise in cancer treatment.
Latest Patents
Masahiro Inaba holds a patent for "Heterocyclic compounds and antitumor agent containing the same as active ingredient." This patent focuses on heterocyclic compounds in which s-triazine or pyrimidine is substituted with benzimidazole and morpholine. These compounds are represented by a specific formula or pharmaceutically acceptable acid addition salts thereof. He has 1 patent to his name.
Career Highlights
Inaba is associated with Zenyaku Kogyo Kabushiki Kaisha, a company that specializes in pharmaceutical development. His work at this organization has been instrumental in advancing research in antitumor therapies.
Collaborations
Throughout his career, Masahiro Inaba has collaborated with notable colleagues, including Seiichiro Kawashima and Toshiyuki Matsuno. These partnerships have contributed to the success of his research and the development of innovative solutions in the pharmaceutical industry.
Conclusion
Masahiro Inaba's contributions to the field of antitumor agents highlight his role as a key innovator in pharmaceuticals. His work continues to inspire advancements in cancer treatment and showcases the importance of research and collaboration in the scientific community.